Five years after it last broached the matter, the Food and Drug Administration (FDA) is again propos...

The Food and Drug Administration (FDA) is extending deadlines for provider and pharmacy certificatio...

Last month, the FDA announced that beginning on October 12, all prescribers of clozapine—a medicatio...

The Food and Drug Administration (FDA) last week approved Vraylar (cariprazine), a dopamine D2/D3 re...

In a paper published in the journal Translational Psychiatry, researchers from Johns Hopkins Univers...

The Food and Drug Administration approved the New Drug Application for Namzaric to treat moderate to...

The Food and Drug Administration (FDA) today issued a proposal designed to assist pharmaceutical com...